Bain Capital Public Equity Management II LLC Grows Stake in Haleon PLC Sponsored ADR $HLN

Key Points

• Bain Capital Public Equity Management II LLC increased its stake in Haleon PLC by 8.8%, now owning approximately 3,093,270 shares worth about $31.83 million, making Haleon the fund's 12th largest position.
• Haleon has recently announced a boost in its semi-annual dividend to $0.0555 per share, reflecting a significant yield of 190.0%, up from its previous dividend of $0.05.
• Analysts have mixed ratings on Haleon, with a consensus rating of "Moderate Buy" and a target price of $12.33, despite a downgrade by Wall Street Zen from "buy" to "hold."

Bain Capital Public Equity Management II LLC boosted its stake in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 8.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,093,270 shares of the company's stock after purchasing an additional 249,260 shares during the period. Haleon comprises approximately 2.5% of Bain Capital Public Equity Management II LLC's investment portfolio, making the stock its 12th biggest position. Bain Capital Public Equity Management II LLC owned approximately 0.07% of Haleon worth $31,830,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Brighton Jones LLC acquired a new stake in shares of Haleon in the 4th quarter valued at about $187,000. First Trust Advisors LP acquired a new stake in shares of Haleon in the 4th quarter valued at about $517,000. Northern Trust Corp grew its stake in shares of Haleon by 27.7% in the 4th quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock valued at $51,636,000 after buying an additional 1,172,931 shares during the period. Schonfeld Strategic Advisors LLC acquired a new stake in shares of Haleon in the 4th quarter valued at about $1,313,000. Finally, Mercer Global Advisors Inc. ADV grew its stake in shares of Haleon by 56.7% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 266,881 shares of the company's stock valued at $2,546,000 after buying an additional 96,574 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HLN has been the topic of several recent research reports. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target on the stock in a research report on Tuesday, May 27th. Finally, Wall Street Zen cut shares of Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $12.33.

Haleon Stock Performance

Shares of NYSE:HLN traded down $0.08 during mid-day trading on Monday, reaching $9.73. The company had a trading volume of 6,102,438 shares, compared to its average volume of 12,628,655. Haleon PLC Sponsored ADR has a one year low of $8.86 and a one year high of $11.42. The firm has a market cap of $43.60 billion, a price-to-earnings ratio of 24.91, a PEG ratio of 2.89 and a beta of 0.24. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The company's 50-day moving average price is $9.78 and its 200-day moving average price is $10.21.

Haleon Increases Dividend

The company also recently declared a semi-annual dividend, which will be paid on Thursday, September 18th. Stockholders of record on Friday, August 15th will be given a dividend of $0.0555 per share. This is an increase from Haleon's previous semi-annual dividend of $0.05. The ex-dividend date is Friday, August 15th. This represents a dividend yield of 190.0%. Haleon's dividend payout ratio (DPR) is presently 28.21%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.